Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $66,018 | $32,657 | $0 | $0 |
Gross Profit | 64,876 | 31,961 | ||
EBITDA | 27,905 | -2,830 | -41,908 | -49,476 |
EBIT | 27,403 | -3,332 | -42,412 | -49,979 |
Net Income | 26,013 | -4,708 | -43,773 | -55,982 |
Net Change In Cash | 66,018 | 32,657 | 0 | 0 |
Free Cash Flow | 43,631 | -12,617 | -32,757 | -23,999 |
Cash | 246,662 | 76,497 | 81,331 | 87,928 |
Basic Shares | 54,921 | 50,483 | 46,179 | 43,924 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,987 | -1,958 | -2,210 | -2,207 |
EBITDA | -173,632 | -37,030 | -22,103 | -30,296 |
EBIT | -175,619 | -38,988 | -24,067 | -32,259 |
Net Income | -175,850 | -38,988 | -24,067 | -30,910 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -69,314 | -24,940 | -20,794 | -27,792 |
Cash | 87,928 | 169,681 | 14,602 | 21,304 |
Basic Shares | 40,175 | 16,492 | 8,397 | 5,318 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.47 |
2025-06-30 | -$0.09 |
2025-03-31 | -$0.95 |
